Population intermediate outcomes of diabetes under pay for performance incentives in England from 2004 to 2008

  1. Pooja Vaghela, MPharm1,
  2. Mark Ashworth, DM2,
  3. Peter Schofield, PhD2 and
  4. Martin C Gulliford, FFPH (martin.gulliford{at}kcl.ac.uk)1
  1. King's College London, Departments of Public Health Sciences1 and
  2. Primary Care and General Practice2

    Abstract

    Objective: To evaluate diabetes outcomes under a national ‘pay-for-performance’ program.

    Research Design and Methods: Data were analysed for 98% of all English family practices. For each practice, the proportion of diabetes subjects with HbA1c ≤7.5%, blood pressure ≤145/85mm Hg and cholesterol ≤5mmol/l was determined. Practices achieving less than the 25th centile for the HbA1c target for 2006-7 were classed as low-performing.

    Results: The proportion achieving the HbA1c target at the median practice increased from 59.1% (interquartile range, IQR 51.7%-65.9%) in 2004-5 to 66.7% (IQR 60.6%-72.7%) in 2007-8; blood pressure from 70.9% in 2004-5 to 80.2% in 2007-8; cholesterol from 72.6% in 2004-5 to 83.6% in 2007-8. In 2004-5, 57% of practices were low-performing, (range by region, 42.4%-69.9%). In 2007-8, 26% of practices were low-performing (range 11.6%-37.5%).

    Conclusion: Introduction of pay-for-performance may be one factor contributing to increasing achievement of targets and reducing problems of low performance.

    Footnotes

      • Received November 6, 2008.
      • Accepted December 11, 2008.